Patents by Inventor Bill N. On

Bill N. On has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8268006
    Abstract: A constrained prosthetic knee having a modular hinge post and a rotating bearing. A cannulated hinge post is rotatably connected to the femoral component of the knee prosthesis so that a hinge post extension may be anteriorly positioned through the hinge post and into the tibial component of the knee prosthesis, after positioning of the femoral component in the femur and the tibial component in the tibia. The hinge post is preassembled to the femoral component so that such assembly is not required during the implantation procedure. A meniscal component forming the rotating bearing of the knee prosthesis is packaged together with the hinge post extension so that the appropriate hinge post extension is readily available. The meniscal component includes a mechanism for preventing lift off of the meniscal component from the tibial component, while allowing rotation of the meniscal component relative to the tibial component.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: September 18, 2012
    Assignee: Zimmer, Inc.
    Inventors: John E. Meyers, G. Doug Letson, Russell Windsor, Vincent A. Webster, Bill N. Sisk, Bill H. Haywood, Adam M. Griner, Michael Cook, Rodney L. Bays, Jerry L. Aikins, Marvin Figueroa, Peter S. Walker
  • Publication number: 20110293554
    Abstract: This invention relates to a recombinant human G-CSF (rhG-CSF) dimer and its use in the treatment of neurological disorder. In particular, upon ischemic neural injury in animal, this invention can be used to protect neurons with the use of rhG-CSF dimer such that function of injured nerves can be restored. Serum half-life of G-CSF dimer of this invention is prolonged and the biological activity thereof is increased.
    Type: Application
    Filed: May 23, 2011
    Publication date: December 1, 2011
    Applicant: GENERON (SHANGHAI) CORPORATION LTD.
    Inventors: Xiaoqiang YAN, Zhihua HUANG, Hongzhou YANG, Bill N.C. SUN, Yuliang HUANG
  • Publication number: 20100234962
    Abstract: A constrained prosthetic knee having a modular hinge post and a rotating bearing. A cannulated hinge post is rotatably connected to the femoral component of the knee prosthesis so that a hinge post extension may be anteriorly positioned through the hinge post and into the tibial component of the knee prosthesis, after positioning of the femoral component in the femur and the tibial component in the tibia. The hinge post is preassembled to the femoral component so that such assembly is not required during the implantation procedure. A meniscal component forming the rotating bearing of the knee prosthesis is packaged together with the hinge post extension so that the appropriate hinge post extension is readily available. The meniscal component includes a mechanism for preventing lift off of the meniscal component from the tibial component, while allowing rotation of the meniscal component relative to the tibial component.
    Type: Application
    Filed: May 28, 2010
    Publication date: September 16, 2010
    Applicant: ZIMMER TECHNOLOGY, INC.
    Inventors: John E. Meyers, G. Doug Letson, Russell Windsor, Vincent A. Webster, Bill N. Sisk, Bill H. Haywood, Adam Griner, Michael Cook, Rodney L. Bays, Jerry L. Aikins, Marvin Figueroa, Peter S. Walker
  • Publication number: 20100036776
    Abstract: The automation of design and sale of electronic and mechanical components is accomplished by allowing a user to design a plan for their electronic and mechanical component needs using specialized software. The software utilizes predefined models of components to aid the user in designing a system where all the components are compatible, even in cases where the components are made by different manufacturers. This is accomplished by creating a model for each proposed piece of equipment in the system, the model having properties and rules, wherein the rules define conditions and actions. Then an object is created for each piece of equipment in the system. Selections for values for the properties are received for each of the pieces of equipment. Any rules that have as a condition the properties for which value selections are received are executed. Finally, testing may be undertaken to determine if a proposed configuration is valid by examining results of the rule execution.
    Type: Application
    Filed: October 16, 2009
    Publication date: February 11, 2010
    Applicant: INTANGI, INC.
    Inventor: Bill N. Musharbash
  • Publication number: 20080181897
    Abstract: The invention relates to agonist molecules which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation. Such agonist molecules include monoclonal antibodies, or fragments, homologues or analogues thereof, or peptides or organic compounds. Two examples of mouse monoclonal agonist antibodies are disclosed: mAb163-93 and mAb174-74-11.
    Type: Application
    Filed: July 7, 2006
    Publication date: July 31, 2008
    Inventors: Baofu Ni, Bill N.C. Sun, Cecily R. Y. Sun
  • Patent number: 7250493
    Abstract: Fc fusion proteins of human EPO with increased biological activities relative to rHuEPO on a molar basis are disclosed. The HuEPO-L-vFc fusion protein comprises HuEPO, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such HuEPO-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: July 31, 2007
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Patent number: 7232668
    Abstract: Fc fusion proteins of human G-CSF with increased biological activities relative to rhG-CSF on a molar basis are disclosed. The hG-CSF-L-vFc fusion protein comprises hG-CSF, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such hG-CSF-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: June 19, 2007
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Patent number: 7226759
    Abstract: Fc fusion proteins of human G-CSF with increased biological activities relative to rhG-CSF on a molar basis are disclosed. The hG-CSF-L-vFc fusion protein comprises hG-CSF, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such hG-CSF-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: March 15, 2004
    Date of Patent: June 5, 2007
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Patent number: 7096164
    Abstract: The automation of design and sale of electronic and mechanical components is accomplished by allowing a user to design a plan for their electronic and mechanical component needs using specialized software. The software utilizes predefined models of components to aid the user in designing a system where all the components are compatible, even in cases where the components are made by different manufacturers. This is accomplished by creating a model for each proposed piece of equipment in the system, the model having properties and rules, wherein the rules define conditions and actions. Then an object is created for each piece of equipment in the system. Selections for values for the properties are received for each of the pieces of equipment. Any rules that have as a condition the properties for which value selections are received are executed. Finally, testing may be undertaken to determine if a proposed configuration is valid by examining results of the rule execution.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: August 22, 2006
    Assignee: Intangi, Inc.
    Inventor: Bill N. Musharbash
  • Patent number: 7030226
    Abstract: Fc fusion proteins of human EPO with increased biological activities relative to rHuEPO on a molar basis are disclosed. The HuEPO-L-vFc fusion protein comprises HuEPO, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such HuEPO-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: April 18, 2006
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Patent number: 6900292
    Abstract: Fc fusion proteins of human EPO with increased biological activities relative to rHuEPO on a molar basis are disclosed. The HuEPO-L-vFc fusion protein comprises HuEPO, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such HuEPO-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: May 31, 2005
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Publication number: 20040265973
    Abstract: Fc fusion proteins of human G-CSF with increased biological activities relative to rhG-CSF on a molar basis are disclosed. The hG-CSF-L-vFc fusion protein comprises hG-CSF, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such hG-CSF-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 30, 2004
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Publication number: 20040259209
    Abstract: Fc fusion proteins of human G-CSF with increased biological activities relative to rhG-CSF on a molar basis are disclosed. The hG-CSF-L-vFc fusion protein comprises hG-CSF, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such hG-CSF-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 23, 2004
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Publication number: 20040249467
    Abstract: A constrained prosthetic knee having a modular hinge post and a rotating bearing. A cannulated hinge post is rotatably connected to the femoral component of the knee prosthesis so that a hinge post extension may be anteriorly positioned through the hinge post and into the tibial component of the knee prosthesis, after positioning of the femoral component in the femur and the tibial component in the tibia. The hinge post is preassembled to the femoral component so that such assembly is not required during the implantation procedure. A meniscal component forming the rotating bearing of the knee prosthesis is packaged together with the hinge post extension so that the appropriate hinge post extension is readily available. The meniscal component includes a mechanism for preventing lift off of the meniscal component from the tibial component, while allowing rotation of the meniscal component relative to the tibial component.
    Type: Application
    Filed: March 19, 2004
    Publication date: December 9, 2004
    Inventors: John E. Meyers, G. Doug Letson, Russell Windsor, Vincent A. Webster, Bill N. Sisk, Bill H. Haywood, Adam Griner, Michael Cook, Rodney L. Bays, Jerry L. Aikins, Marvin Figueroa, Peter S. Walker
  • Patent number: 6797493
    Abstract: Fc fusion proteins of human G-CSF with increased biological activities relative to rhG-CSF on a molar basis are disclosed. The hG-CSF-L-vFc fusion protein comprises hG-CSF, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such hG-CSF-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: September 28, 2004
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Publication number: 20040175824
    Abstract: Fc fusion proteins of human EPO with high biological activities relative to rHuEPO on a molar basis are disclosed. The HuEPO-L-vFc fusion protein comprises HuEPO, a flexible peptide linker of about 20 or fewer amino acids, and a human IgG Fc variant. The Fc variant is of a non-lytic nature and shows minimal undesirable Fc-mediated side effects. A method is also disclosed to make or produce such fusion proteins at high expression levels. Such HuEPO-L-vFc fusion proteins exhibit extended serum half-life and increased biological activities, leading to improved pharmacokinetics and pharmacodynamics, thus fewer injections will be needed within a period of time.
    Type: Application
    Filed: January 21, 2004
    Publication date: September 9, 2004
    Inventors: Lee-Hwei K. Sun, Bill N. C. Sun, Cecily R. Y. Sun
  • Patent number: 6773461
    Abstract: A constrained prosthetic knee having a modular hinge post and a rotating bearing. A cannulated hinge post is rotatably connected to the femoral component of the knee prosthesis so that a hinge post extension may be anteriorly positioned through the hinge post and into the tibial component of the knee prosthesis, after positioning of the femoral component in the femur and the tibial component in the tibia. The hinge post is preassembled to the femoral component so that such assembly is not required during the implantation procedure. A meniscal component forming the rotating bearing of the knee prosthesis is packaged together with the hinge post extension so that the appropriate hinge post extension is readily available.
    Type: Grant
    Filed: September 4, 2002
    Date of Patent: August 10, 2004
    Assignee: Zimmer Technology, Inc.
    Inventors: John E. Meyers, G. Douglas Letson, Russell Windsor, Vincent A. Webster, Bill N. Sisk, Bill H. Haywood, Adam Griner, Michael Cook, Rodney L. Bays, Jerry L. Aikins, Marvin Figueroa
  • Patent number: 6719800
    Abstract: A constrained prosthetic knee having a modular hinge post and a rotating bearing. A cannulated hinge post is rotatably connected to the femoral component of the knee prosthesis so that a hinge post extension may be anteriorly positioned through the hinge post and into the tibial component of the knee prosthesis, after positioning of the femoral component in the femur and the tibial component in the tibia. The hinge post is preassembled to the femoral component so that such assembly is not required during the implantation procedure. A meniscal component forming the rotating bearing of the knee prosthesis is packaged together with the hinge post extension so that the appropriate hinge post extension is readily available. The meniscal component includes a mechanism for preventing lift off of the meniscal component from the tibial component, while allowing rotation of the meniscal component relative to the tibial component.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: April 13, 2004
    Assignee: Zimmer Technology, Inc.
    Inventors: John E. Meyers, G. Doug Letson, Russell Windsor, Vincent A. Webster, Bill N. Sisk, Bill H. Haywood, Adam Griner, Michael Cook, Rodney L. Bays, Jerry L. Aikins, Marvin Figueroa
  • Patent number: 6657050
    Abstract: Chimeral viral-neutralizing, particularly HIV-neutralizing, immunoglobulins made up of a non-human antigen binding region and a human constant region are described.
    Type: Grant
    Filed: February 5, 1993
    Date of Patent: December 2, 2003
    Assignee: Tanox, Inc.
    Inventors: Cecily R. Y. Sun, Bill N. C. Sun, Michael S. C. Fung, Tse Wen Chang, Nancy T. Chang
  • Patent number: 6654241
    Abstract: A novel high availability small foot-print server is described in which four or more separate computer modules and associated power supply and communication connections or other units are clustered together in a single server chassis to occupy a limited amount of space while providing maximum accessibility for administrative, maintenance, installation, or other purposes. Each separate computer module is equipped with its own fan or blower box to provide redundancy in the case of fan or blower box failure. The server chassis is contoured to provide for natural interconnection such that more than one high availability small foot-print server may be stacked together to take up the same amount of floor, shelf, or desk space as a single server.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: November 25, 2003
    Assignee: Intel Corporation
    Inventors: David R. Hillyard, Bill N. Gallas, Mark D. Summers